Pulse Biosciences, Inc. (PLSE) stock
PLSENasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
$50.44−1.81 (-3.46%)
Close on Nov 13, 2026Market cap $3.60BP/E –Yield –
Pulse Biosciences enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Pulse Biosciences's enterprise value was $3.93B on Nov 11, 2026, against $832.12M a year earlier. Over the last 5 years it ranged from $5.29M to $3.93B, with a median of $622.70M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $3.93B | +371.1% |
| 2025 | Dec 31, 2025 | $834.83M | -15.8% |
| 2024 | Dec 31, 2024 | $991.96M | +59.3% |
| 2023 | Dec 29, 2023 | $622.70M | +1733.7% |
| 2022 | Dec 30, 2022 | $33.96M | -91.4% |
| 2021 | Dec 31, 2021 | $396.84M | -30.8% |
| 2020 | Dec 31, 2020 | $573.82M | +134.9% |
| 2019 | Dec 31, 2019 | $244.27M | +40.7% |
| 2018 | Dec 31, 2018 | $173.62M | -49.5% |
| 2017 | Dec 29, 2017 | $343.61M | +406.5% |
| 2016 | Dec 30, 2016 | $67.83M | – |
See a number that looks wrong?